tradmap

HLF Herbalife Ltd.

$12.16 -0.08%

Updated

Industrials · Wholesale-Drugs, Proprietaries & Druggists' Sundries

Herbalife Ltd. (HLF) is a industrials company in the Wholesale-Drugs, Proprietaries & Druggists' Sundries industry, with a market capitalization of $1.3 billion. Shares last traded at $12.16, 40.2% below their 52-week high. Over the past year the stock is up 22.2%. HLF trades at a price-to-earnings ratio of 7.76, below the Wholesale-Drugs, Proprietaries & Druggists' Sundries median of 23.95. Net profit margin is 3.2%, above the peer median of 0.7%. Revenue grew 0.9% year over year. The shares yield 7.4% in dividends.

Market Cap
$1.3B
Shares Out
104.8M
EPS (TTM)
$3.25
P/E Ratio
3.74
P/S Ratio
0.25
P/B Ratio
Dividend / Share
$0.90
Dividend Yield
7.40%
52-Week High
$20.34
52-Week Low
$7.58
Volume
71,045
Avg Vol (3m)
86,103.968

Performance

1W
-1.70%
1M
-3.49%
3M
+6.71%
6M
-24.85%
YTD
-5.30%
1Y
+22.21%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
49.60
SMA (50)
$12.36
SMA (200)
$14.07
Price vs SMA50
-1.64%
Price vs SMA200
-13.55%
ATR (14)
$0.61

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$5.2B
Net Income
$164M
Gross Margin
77.7%
Operating Margin
9.5%
Net Margin
3.2%
Return on Equity
-34.6%
Return on Assets
5.7%
Current Ratio
1.20
Debt / Equity
-4.25
Revenue Growth (YoY)
+0.9%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

HLF Dividend History

Dividend / share (TTM)
$0.90
Dividend yield
7.40%
Per-share growth (3y CAGR)
-21.2%
Payout ratio (latest FY)
10%
Fiscal year endTotal dividends paidPer share*Payout ratio
2014-12-31 $30M $0.33 10%
2013-12-31 $123M $1.15 23%
2012-12-31 $135M $1.15 29%
2011-12-31 $85M $0.68 21%

*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts). Reported history — not a forecast of future dividends.

Compare payers on the highest-dividend-yield screener.

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $0.33 2026-08-05
Q1 2026 $0.57 2026-05-06
FY 2025 $2.20 2026-02-18
Q3 2025 $1.38 2025-11-05
Q2 2026 $0.97 2026-08-05
Q1 2026 $0.49 2026-05-06

Full earnings history →

Wholesale-Drugs, Proprietaries & Druggists' Sundries peers

HLF vs 9 industry peers (Wholesale-Drugs, Proprietaries & Druggists' Sundries), by market cap. Updated

P/E vs peers
7.76 / 23.95 med
-68% discount
P/S vs peers
0.25 / 0.24 med
+2% premium
Net margin vs peers
3.2% / 0.7% med
above median
1–9 of 9
MCKMcKesson Corporation$107.4B23.390.261.1%-0.40%
CORCencora$64.3B24.510.190.8%+0.23%
CAHCardinal Health$57.8B34.780.240.7%+1.24%
HLFHerbalife Ltd.$1.3B7.760.253.2%-0.08%
NUSNU SKIN ENTERPRISES, INC.$228M-1.050.17-15.7%-2.90%
COSMCosmos Health Inc.$27M-1.100.37-33.1%+18.78%
HWHHWH International Inc.$15M-5.54+2.98%
MEDSDataMeds AI, Inc.$3M-0.03-4.49%
HKPDCellyan Biotechnology Co., Ltd-7.89%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.